Combined Application of Pan-AKT Inhibitor MK-2206 and BCL-2 Antagonist Venetoclax in B-Cell Precursor Acute Lymphoblastic LeukemiaAnna Richter, Christian Junghanss|International Journal of Molecular Sciences|2021Cited by 16